Clinical Trial Update: Study Evaluating Safety, Tolerability, and Metabolism of Niraparib [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating safety, tolerability, and metabolism of Niraparib in ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: University of Miami | Conditions: Ovarian Cancer | Phase 4 | Status: RECRUITING